Hemington Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3K Sell
62
-27
-30% -$1.88K ﹤0.01% 1273
2025
Q2
$7K Buy
89
+6
+7% +$502 ﹤0.01% 992
2025
Q1
$7K Buy
83
+23
+38% +$1.89K ﹤0.01% 944
2024
Q4
$4K Buy
60
+17
+40% +$1.32K ﹤0.01% 1103
2024
Q3
$3K Buy
+43
New +$3.04K ﹤0.01% 1095

Other funds holding PBH

Hemington Wealth Management's PBH Position: Q3 2025 in Review

Hemington Wealth Management reduced its Prestige Consumer Healthcare (PBH) stake by 30% in Q3 2025, selling an estimated $1.88K and leaving 62 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Hemington Wealth Management first reported a position in PBH in Q3 2024 and has held it in 5 quarters since. The position peaked at $7K in Q2 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Hemington Wealth Management held 62 shares of Prestige Consumer Healthcare worth $3K as of Q3 2025.
  • Hemington Wealth Management sold 27 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.88K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1273 holding.
  • Hemington Wealth Management first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Prestige Consumer Healthcare position peaked at $7K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.